Zentalis Pharmaceuticals Inc. is a biopharmaceutical company that develops and delivers targeted small molecule therapeutics to treat oncology-related diseases. With its innovative approach and cutting-edge research, Zentalis aims to provide patients with effective and personalized treatments for a wide range of cancers.
